Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)
Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
An open label, balanced, randomized, single-dose, two-treatment, two-sequence, two-period,
crossover oral drug-drug interaction study of spironolactone (perpetrator) and Digoxin
(substrate drug) in healthy adult human subjects under fasting condition.